Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus
Introduction of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revas...
Enregistré dans:
Auteurs principaux: | Marina Sergeevna Michurova, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova, Victor Yur'evich Kalashnikov |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e58e32fb4e6c43c8a05590da5d4e18bb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mobilization of endothelial progenitor cells after endovascular interventions in patients with type 2 diabetes mellitus
par: Marina Sergeevna Michurova, et autres
Publié: (2014) -
Endothelial progenitor cells and vascular endothelial growth factor after endovascular interventions in patients with type 2 diabetes
par: Marina Sergeevna Michurova, et autres
Publié: (2017) -
Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
par: Olga Mikhailovna Smirnova, et autres
Publié: (2012) -
Long-term comparison of everolimus- vs.
novolimus-eluting bioresorbable vascular scaffolds
in real world patients
par: Beytullah Cakal, et autres
Publié: (2020) -
Myocardial revascularization in patients with type 2 diabetes mellitus: An overview of modern techniques
par: Elena Zelikovna Golukhova, et autres
Publié: (2016)